Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Cytek Biosciences (CTKB) Research & Development (2020 - 2026)

Cytek Biosciences filings provide 6 years of Research & Development readings, the most recent being $9.0 million for Q4 2025.

  • On a quarterly basis, Research & Development fell 7.83% to $9.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $36.5 million, a 7.44% decrease, with the full-year FY2025 number at $36.5 million, down 7.45% from a year prior.
  • Research & Development hit $9.0 million in Q4 2025 for Cytek Biosciences, roughly flat from $9.0 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $12.1 million in Q2 2023 to a low of $5.1 million in Q1 2021.
  • Median Research & Development over the past 5 years was $9.3 million (2024), compared with a mean of $9.0 million.
  • Biggest five-year swings in Research & Development: surged 112.41% in 2021 and later dropped 17.59% in 2024.
  • Cytek Biosciences' Research & Development stood at $7.1 million in 2021, then surged by 37.75% to $9.7 million in 2022, then rose by 11.51% to $10.9 million in 2023, then decreased by 10.54% to $9.7 million in 2024, then fell by 7.83% to $9.0 million in 2025.
  • The last three reported values for Research & Development were $9.0 million (Q4 2025), $9.0 million (Q3 2025), and $8.8 million (Q2 2025) per Business Quant data.